0
0
40 words
0
Comments
Pharmaceutical giant Novo Nordisk said it is slashing the price of weight-loss and diabetes drugs Ozempic, Wegovy and Rybelsus by more than a third.
You are the first to view
https://www.forbes.com/sites/mikestunson/2026/02/24/ozempic-and-wegovy-prices-will-be-cut-next-year-drug-maker-says/
Create an account or login to join the discussion